Clinical Tools | Medical XPRT
Articles & Whitepapers
-
Lipids Used in COVID-19 mRNA Vaccines
The COVID-19 pandemic has killed millions of people. Vaccines certainly are the most outstanding ways to prevent major diseases and death, though they haven't eliminated infections. At present, the most effective vaccine is the mRNA vaccine developed by Pfizer-BioNTech and Moderna. Before that, mRNA technology stopped in the lab phase. How to apply mRNA technology to more complex diseases in the ...
-
Hypoglycemic Functional Factors in Natural Products and Their Mechanisms of Action
Diabetes is a common clinical disease, and with the improvement of living standards, an increase in the number of obese people, and the intensification of aging populations, the incidence of diabetes ...
News
-
Koning Ends the Year with $2.6M Republic Raise
NORCROSS, Ga., Feb. 1, 2022 /PRNewswire/ -- Koning, a growing medical device startup company based outside Atlanta, had a successful conclusion to 2021. The company recently finished their first Republic crowdfunding campaign, exceeding capital ...
Corify Care participated in the CEI Satellite Meeting CinC 2020: Challenges in the Daily Application of ECGI
Empatica Announces EmbracePlus: NASA Medical Quality in a Down-to-Earth Smart Watch
Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared Fluorescence Visualization, Expanding Application of Existing Robotic Exoscope
How ReFlow Helped Get Zachary’s Hydrocephalus Under Control and Travel Across the Globe
Equipment & Solutions
-
Showcase
Electrolyte Analyzer
Electrolyte analyzers are indispensable in clinical testing. In clinical practice, it mainly tests and maintains the balance of osmotic pressure in human blood and body fluids; in surgery, burns, diarrhea, acute myocardial infarction and other patients who need a large amount of balanced fluid replacement, the test and detection of ions are very important. EA Series Electrolyte Analyzers are ...
Upcoming Events
-
Showcase
The 7th Global MASLD Congress
MASH/MASLD incidence rates are continuing to rise globally year after year as the disease continues to be a global health concern. Although no pharmaceutical drugs have yet received regulatory approval, there are a number of therapeutics in late phase clinical trials; case studies of which will be discussed at the congress as well as pre-clinical developments. Potential alternatives for MASH ...